The objective of this study was to describe clinico-laboratory parameters, outcome and predictors of scrub typhus co- infection in COVID-19 affected children. Ours was a retrospective analysis done in a tertiary care pediatric COVID facility. COVID-19 positive children in the age group of 1 month to 12 years who were tested for scrub typhus co-infection between May to August 2020 were included in the study. In all positive cases, clinical, laboratory, treatment and outcome data were analyzed. Relevant data were compared between scrub typhus confirmed, and suspected but negative patients. All six patients with co-infection had fever for >5 days and four had features of cerebral involvement. These had lymphocytic pleocytosis in cerebrospinal fluid (CSF) analysis and two had eschar. Screening for scrub typhus in persistently febrile children residing in highly endemic areas is highly recommended.

中文翻译：

---

对 covid-19 受影响儿童的恙虫病合并感染的临床实验室参数、结果和预测因素进行回顾性分析。

本研究的目的是描述受 COVID-19 影响的儿童中恙虫病合并感染的临床实验室参数、结果和预测因素。我们的回顾性分析是在一家三级儿科新冠肺炎医疗机构中进行的。该研究纳入了 2020 年 5 月至 8 月期间接受恙虫病合并感染检测的 1 个月至 12 岁年龄组的 COVID-19 阳性儿童。对所有阳性病例的临床、实验室、治疗和结果数据进行了分析。对确诊的恙虫病患者和疑似但阴性的患者之间的相关数据进行了比较。所有 6 名合并感染患者均发烧超过 5 天，其中 4 名患者有脑部受累的特征。脑脊液 (CSF) 分析显示这些患者淋巴细胞增多，其中两人有焦痂。强烈建议对居住在高流行地区的持续发热儿童进行恙虫病筛查。